Personal information

No personal information available

Activities

Collapse all

Employment (1)

Belgian Nuclear Research Centre: Mol, BE

2019-03-18 to present | Research Scientist (Research in Dosimetric Applications)
Employment
Source: Self-asserted source
Melissa Crabbé

Education and qualifications (1)

KU Leuven Research and Development: Leuven, BE

2014-09-01 to present | PhD candidate (Imaging and pathology)
Education
Source: Self-asserted source
Melissa Crabbé

Funding (1)

In vivo study of the metabotropic glutamate receptor type 5 in relation to adenosine signaling and neuroinflammation in experimental Parkinson's disease

Grant
Fonds Wetenschappelijk Onderzoek (Brussels, BE)
Source: Self-asserted source
Melissa Crabbé

Works (14)

Targeted radiopharmaceuticals: an underexplored strategy for ovarian cancer

Theranostics
2024 | Journal article
DOI: 10.7150/thno.99782
Part of ISSN: 1838-7640
Contributors: Melissa Crabbé; Tomas Opsomer; Koen Vermeulen; Maarten Ooms; Charlotte Segers
Source: Self-asserted source
Melissa Crabbé

The Emission of Internal Conversion Electrons Rather Than Auger Electrons Increased the Nucleus-Absorbed Dose for<sup>161</sup>Tb Compared with<sup>177</sup>Lu with a Higher Dose Response for [<sup>161</sup>Tb]Tb-DOTA-LM3 Than for [<sup>161</sup>Tb]Tb-DOTATATE

Journal of Nuclear Medicine
2024-10 | Journal article
DOI: 10.2967/jnumed.124.267873
Part of ISSN: 0161-5505
Part of ISSN: 2159-662X
Contributors: Kaat Spoormans; Lara Struelens; Koen Vermeulen; Marijke De Saint-Hubert; Michel Koole; Melissa Crabbé
Source: Self-asserted source
Melissa Crabbé

Preclinical evaluation of CXCR4 peptides for targeted radionuclide therapy in glioblastoma

EJNMMI Radiopharmacy and Chemistry
2024-07-15 | Journal article
DOI: 10.1186/s41181-024-00282-y
Part of ISSN: 2365-421X
Contributors: Anthony Waked; Melissa Crabbé; Virginie Neirinckx; Sunay Rodriguez Pérez; Jasmien Wellens; Bernard Rogister; M. Abderrafi Benotmane; Koen Vermeulen
Source: Self-asserted source
Melissa Crabbé

Exploring the Potential of High-Molar-Activity Samarium-153 for Targeted Radionuclide Therapy with [153Sm]Sm-DOTA-TATE

Pharmaceutics
2022-11-23 | Journal article
DOI: 10.3390/pharmaceutics14122566
Contributors: Koen Vermeulen; Michiel Van de Voorde; Charlotte Segers; Amelie Coolkens; Sunay Rodriguez Pérez; Noami Daems; Charlotte Duchemin; Melissa Crabbé; Tomas Opsomer; Clarita Saldarriaga Vargas et al.
Source: check_circle
Crossref
grade
Preferred source (of 2)‎

A Review on Tumor Control Probability (TCP) and Preclinical Dosimetry in Targeted Radionuclide Therapy (TRT)

Pharmaceutics
2022-09-22 | Journal article | Author
DOI: 10.3390/pharmaceutics14102007
Part of ISSN: 1999-4923
Contributors: Kaat Spoormans; Melissa Crabbé; 0000-0003-4696-9370; Marijke De Saint-Hubert; Michel Koole
Source: Self-asserted source
Melissa Crabbé
grade
Preferred source (of 3)‎

Review of extremity dosimetry in nuclear medicine

Journal of Radiological Protection
2021-12-01 | Journal article
DOI: 10.1088/1361-6498/ac31a2
Contributors: Robert Kollaard; Alessandra Zorz; Jérémie Dabin; Peter Covens; Jennie Cooke; Melissa Crabbé; Lidia Cunha; Anita Dowling; Mercè Ginjaume; Leanne McNamara
Source: check_circle
Crossref

Non-invasive characterization of amyotrophic lateral sclerosis in a hTDP-43A315T mouse model: A PET-MR study

NeuroImage: Clinical
2020 | Journal article
DOI: 10.1016/j.nicl.2020.102327
Part of ISSN: 2213-1582
Source: Self-asserted source
Melissa Crabbé

Targeted alpha therapy: a critical review of translational dosimetry research with emphasis on actinium-225

The Quarterly Journal of Nuclear Medicine and Molecular Imaging
2020-07 | Journal article
DOI: 10.23736/S1824-4785.20.03266-5
Source: Self-asserted source
Melissa Crabbé

Role of the GLUT1 Glucose Transporter in Postnatal CNS Angiogenesis and Blood-Brain Barrier Integrity

Circulation Research
2020-07-31 | Journal article
DOI: 10.1161/circresaha.119.316463
Part of ISSN: 0009-7330
Part of ISSN: 1524-4571
Contributors: Koen Veys; Zheng Fan; Moheb Ghobrial; Ann Bouché; Melissa García-Caballero; Kim Vriens; Nadine Vasconcelos Conchinha; Aline Seuwen; Felix Schlegel; Tatiane Gorski et al.
Source: Self-asserted source
Melissa Crabbé

Excitotoxic neurodegeneration is associated with a focal decrease in metabotropic glutamate receptor type 5 availability: an in vivo PET imaging study

Scientific Reports
2019-12 | Journal article
DOI: 10.1038/s41598-019-49356-x
Part of ISSN: 2045-2322
Source: Self-asserted source
Melissa Crabbé

Regional changes in the type 1 cannabinoid receptor are associated with cognitive dysfunction in Parkinson’s disease

European Journal of Nuclear Medicine and Molecular Imaging
2019-10 | Journal article
DOI: 10.1007/s00259-019-04445-x
Part of ISSN: 1619-7070
Part of ISSN: 1619-7089
Contributors: Jenny Ceccarini; Cindy Casteels; Rawaha Ahmad; Melissa Crabbé; Laura Van de Vliet; Heleen Vanhaute; Mathieu Vandenbulcke; Wim Vandenberghe; Koen Van Laere
Source: Self-asserted source
Melissa Crabbé

Temporal changes in neuroinflammation and brain glucose metabolism in a rat model of viral vector-induced α-synucleinopathy

Experimental Neurology
2019-10 | Journal article
DOI: 10.1016/j.expneurol.2019.112964
Contributors: Melissa Crabbé; Anke Van der Perren; Savannah Kounelis; Thomas Lavreys; Guy Bormans; Veerle Baekelandt; Cindy Casteels; Koen Van Laere
Source: check_circle
Crossref

Increased P2X7 Receptor Binding Is Associated With Neuroinflammation in Acute but Not Chronic Rodent Models for Parkinson’s Disease

Frontiers in Neuroscience
2019-07-31 | Journal article
DOI: 10.3389/fnins.2019.00799
Part of ISSN: 1662-453X
Source: Self-asserted source
Melissa Crabbé

Altered mGluR5 binding potential and glutamine concentration in the 6-OHDA rat model of acute Parkinson's disease and levodopa-induced dyskinesia.

Neurobiology of Aging
Journal article
Source: Self-asserted source
Melissa Crabbé
How many people are using ORCID?